Argenx Se (ARGX) Income towards Parent Company (2016 - 2026)

Argenx Se (ARGX) posted Income towards Parent Company of $366.0 million for Q1 2026, down 31.33% on a QoQ basis from $532.9 million in Q4 2025, and up 116.57% year-over-year from $169.0 million in Q1 2025.

Argenx Se (ARGX) Income towards Parent Company (2016 - 2026) Analysis & Trends

Argenx Se's Income towards Parent Company history runs 11 years deep, the most recent figure standing at $366.0 million for Q1 2026.

  • Quarterly Income towards Parent Company rose 116.57% year-over-year to $366.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 39.95% YoY) and the FY2025 annual result came in at $1.3 billion, up 55.1% from the prior year.
  • Income towards Parent Company was $366.0 million for Q1 2026 at Argenx Se, down from $532.9 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $774.2 million in Q4 2024 and bottomed at -$235.0 million in Q3 2022.
  • A 5-year average of $138.7 million and a median of $29.1 million in 2024 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 461.88% — and 2024, when it soared 880.62%.
  • Argenx Se's Income towards Parent Company stood at -$38.6 million in 2022, then slumped by 156.84% to -$99.2 million in 2023, then surged by 880.62% to $774.2 million in 2024, then tumbled by 31.16% to $532.9 million in 2025, then slumped by 31.33% to $366.0 million in 2026.
  • Business Quant data shows ARGX's Income towards Parent Company at $366.0 million in Q1 2026, $532.9 million in Q4 2025, and $344.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 366.00 Mn
Dec 31, 2025 532.95 Mn
Sep 30, 2025 344.26 Mn
Jun 30, 2025 245.36 Mn
Mar 31, 2025 169.00 Mn
Dec 31, 2024 774.16 Mn
Sep 30, 2024 91.41 Mn
Jun 30, 2024 29.07 Mn
Mar 31, 2024 -61.60 Mn
Dec 31, 2023 -99.17 Mn
Sep 30, 2023 -72.64 Mn
Jun 30, 2023 -94.37 Mn
Mar 31, 2023 -28.87 Mn
Dec 31, 2022 -38.61 Mn
Sep 30, 2022 -235.04 Mn
Jun 30, 2022 663.12 Mn
Mar 31, 2022 -227.19 Mn
Dec 31, 2021 -237.82 Mn
Sep 30, 2021 -233.61 Mn
Jun 30, 2021 103.60 Mn